The global cerebrospinal fluid management market was valued at USD 1.20 Billion in 2016 and is projected to reach USD 1.56 Billion by 2022, at a CAGR of 4.4%. Base year considered for the report is 2016 and the forecast period considered for this report is 2017–2022.
The Report “Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022”
To speak to our analyst for a discussion on the above findings, click:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=160672575
The Report “Cerebrospinal Fluid Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022”
To speak to our analyst for a discussion on the above findings, click:- https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=160672575
Top-down and bottom-up approaches were used to validate the size of the global cerebrospinal fluid management market and estimate the size of other dependent submarkets.
Various secondary sources such as Food and Drug Administration (FDA), Hydrocephalus Association, World Health Organization (WHO), National Hydrocephalus Foundation (NHF), Pediatric Hydrocephalus Foundation (PHF), International Federation for Spina Bifida and Hydrocephalus (IFSBH), Hydrocephalus Clinical Research Network, Pacific Adult Hydrocephalus Center, Press Releases, Directories, Industry journals, Databases, and Annual Reports of the companies have been used to identify and collect information useful for the global study of cerebrospinal fluid management industry.
Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.
To know about the assumptions considered for the study, download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160672575
The major players in the global cerebrospinal fluid management market are Medtronic plc (Ireland), Integra LifeSciences Holdings Corporation (US), B. Braun Melsungen AG (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
Various secondary sources such as Food and Drug Administration (FDA), Hydrocephalus Association, World Health Organization (WHO), National Hydrocephalus Foundation (NHF), Pediatric Hydrocephalus Foundation (PHF), International Federation for Spina Bifida and Hydrocephalus (IFSBH), Hydrocephalus Clinical Research Network, Pacific Adult Hydrocephalus Center, Press Releases, Directories, Industry journals, Databases, and Annual Reports of the companies have been used to identify and collect information useful for the global study of cerebrospinal fluid management industry.
Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market.
To know about the assumptions considered for the study, download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=160672575
The major players in the global cerebrospinal fluid management market are Medtronic plc (Ireland), Integra LifeSciences Holdings Corporation (US), B. Braun Melsungen AG (Germany), DePuy Synthes (US), Spiegelberg GmbH & Co. KG (Germany), SOPHYSA (France), Natus Medical Incorporated (US), Dispomedica GmbH (Germany), Delta Surgical Limited (UK), Argi Grup (Turkey), Moller Medical GmbH (Germany), G. SURGIWEAR LTD. (India), and Wellong Instruments Co., Ltd. (Taiwan).
Comments
Post a Comment